Gaining the patient perspective on pelvic floor disorders' surgical adverse events.


Journal

American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476

Informations de publication

Date de publication:
02 2019
Historique:
received: 12 06 2018
revised: 11 10 2018
accepted: 19 10 2018
pubmed: 8 1 2019
medline: 29 10 2019
entrez: 8 1 2019
Statut: ppublish

Résumé

The Institute for Healthcare Improvement defines an adverse event as an unintended physical injury resulting from or contributed to by medical care that requires additional monitoring, treatment, or hospitalization or that results in death. The majority of research has focused on adverse events from the provider's perspective. The objective of this qualitative study was to describe patient perceptions on adverse events following surgery for pelvic floor disorders. Women representing the following 3 separate surgical populations participated in focus groups: (1) preoperative (women <12 weeks prior to surgery); (2) short-term postoperative (women up to 12 weeks after surgery); and (3) long-term postoperative (women 1-5 years after surgery). Deidentified transcripts of audio recordings were coded and analyzed with NVivo 10 software to identify themes, concepts, and adverse events. Women were asked to rank patient-identified and surgeon-identified adverse events in order of perceived severity. Eighty-one women participated in 12 focus groups. Group demographics were similar between groups, and all groups shared similar perspectives regarding surgical expectations. Women commonly reported an unclear understanding of their surgery and categorized adverse events such as incontinence, constipation, nocturia, and lack of improvement in sexual function as very severe, ranking these comparably with intensive care unit admissions or other major surgical complications. Women also expressed a sense of personal failure and shame if symptoms recurred. Women consider functional outcomes such as incontinence, sexual dysfunction, and recurrence of symptoms as severe adverse events and rate them as similar in severity to intensive care unit admissions and death.

Sections du résumé

BACKGROUND
The Institute for Healthcare Improvement defines an adverse event as an unintended physical injury resulting from or contributed to by medical care that requires additional monitoring, treatment, or hospitalization or that results in death. The majority of research has focused on adverse events from the provider's perspective.
OBJECTIVE
The objective of this qualitative study was to describe patient perceptions on adverse events following surgery for pelvic floor disorders.
STUDY DESIGN
Women representing the following 3 separate surgical populations participated in focus groups: (1) preoperative (women <12 weeks prior to surgery); (2) short-term postoperative (women up to 12 weeks after surgery); and (3) long-term postoperative (women 1-5 years after surgery). Deidentified transcripts of audio recordings were coded and analyzed with NVivo 10 software to identify themes, concepts, and adverse events. Women were asked to rank patient-identified and surgeon-identified adverse events in order of perceived severity.
RESULTS
Eighty-one women participated in 12 focus groups. Group demographics were similar between groups, and all groups shared similar perspectives regarding surgical expectations. Women commonly reported an unclear understanding of their surgery and categorized adverse events such as incontinence, constipation, nocturia, and lack of improvement in sexual function as very severe, ranking these comparably with intensive care unit admissions or other major surgical complications. Women also expressed a sense of personal failure and shame if symptoms recurred.
CONCLUSION
Women consider functional outcomes such as incontinence, sexual dysfunction, and recurrence of symptoms as severe adverse events and rate them as similar in severity to intensive care unit admissions and death.

Identifiants

pubmed: 30612960
pii: S0002-9378(18)30917-7
doi: 10.1016/j.ajog.2018.10.033
pmc: PMC6351201
mid: NIHMS1510815
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

185.e1-185.e10

Subventions

Organisme : NICHD NIH HHS
ID : U10 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054215
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069006
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001449
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069013
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : U24 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : L30 HD085503
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069025
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Obstet Gynecol. 2014 May;123(5):1023-30
pubmed: 24785855
BJOG. 2008 Oct;115(11):1362-8
pubmed: 18715245
N Engl J Med. 2012 Nov 8;367(19):1803-13
pubmed: 23036134
N Engl J Med. 2006 Apr 13;354(15):1557-66
pubmed: 16611949
Int Urogynecol J. 2011 Sep;22(9):1159-63
pubmed: 21604059
N Engl J Med. 2012 Jun 21;366(25):2358-67
pubmed: 22716974
Int Urogynecol J. 2010 May;21(5):523-8
pubmed: 20013110
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Am J Obstet Gynecol. 2003 Dec;189(6):1551-7; discussion 1557-8
pubmed: 14710061
Neurourol Urodyn. 2014 Jan;33(1):85-9
pubmed: 23423738
Am J Obstet Gynecol. 2001 Dec;185(6):1388-95
pubmed: 11744914
Am J Obstet Gynecol. 2013 Jan;208(1):81.e1-9
pubmed: 23131463
J Am Coll Surg. 2008 Aug;207(2):240-5
pubmed: 18656053
Am J Obstet Gynecol. 2008 May;198(5):575.e1-6
pubmed: 18313632
Am J Obstet Gynecol. 2013 Nov;209(5):488.e1-5
pubmed: 23770473
JAMA. 2018 Apr 17;319(15):1554-1565
pubmed: 29677302

Auteurs

Gena C Dunivan (GC)

Division of Urogynecology, Department of Obstetrics-Gynecology, University of New Mexico, Albuquerque, NM. Electronic address: gdunivan@salud.unm.edu.

Andrew L Sussman (AL)

Department of Family and Community Medicine, University of New Mexico, Albuquerque, NM.

J Eric Jelovsek (JE)

Department of Obstetrics-Gynecology, Duke University, Durham, NC.

Vivian Sung (V)

Department of Obstetrics-Gynecology, Brown University, Providence, RI.

Uduak U Andy (UU)

Department of Obstetrics-Gynecology, University of Pennsylvania.

Alicia Ballard (A)

Department of Obstetrics-Gynecology, University of Alabama, Birmingham, AL.

Sharon Jakus-Waldman (S)

Department of Obstetrics-Gynecology, Bellflower Medical Center, Bellflower, CA.

Cindy L Amundsen (CL)

Department of Obstetrics-Gynecology, Duke University, Durham, NC.

Christopher J Chermansky (CJ)

Division of Urology, University of Pittsburgh, Pittsburgh, PA.

Carla M Bann (CM)

Division of Statistical and Data Sciences, RTI International, Research Triangle Park, NC.

Donna Mazloomdoost (D)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.

Rebecca G Rogers (RG)

Dell Medical School, Department of Women's Health, University of Texas at Austin, Austin, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH